Thijs Spigt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hits: 1900
- Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland
ROTTERDAM, The Netherlands I February 8, 2021 I Pan Cancer T B.V., a biotech spin-off from the Erasmus Medical Center founded by Prof. Dr. Reno Debets (CSO) and Dr. Dora Hammerl (VP R&D), announces the closing of a seed investment and start of operations. Together with Katrien Reynders-Frederix (CEO), the team is committed to the discovery and development of novel TCR therapies against solid tumors such as triple negative breast cancer, bladder cancer, lung cancer, and glioma. Seed investors are Swanbridge Capital and Van Herk Ventures, and the Company is further awarded a Health~Holland grant for a public-private-partnership with Erasmus Medical Center. ....

Zuid Holland , Thijs Spigt , Cillian King , Van Herk , Reno Debets , Katrien Reynders Frederix , Zealand Pharma , Van Herk Groep , Technology Transfer Office , Professor At Erasmus Medical Center , Health Holland , Erasmus Medical Center Rotterdam , Erasmus Medical Center , Company Pan Cancert Launched As , Onco Immunology Company Pan Cancert Launched , T Cell Receptor , Swanbridge Capital , Van Herk Ventures , Netherlandsi February , Dora Hammerl , Erasmus Medical , Chimeric Antigen Receptor , Erasmus Medical Centerrotterdam , Investment Manager , Swanbrigde Capital , Herk Ventures ,